Freshfields advised Roivant on Sale of Telavant to Roche. Switzerland’s Roche (ROG.S) has entered into an agreement to pay an initial $7.1 billion to Roivant (ROIV.O)...
Roche’s $7.1bn Acquisition of Roivant from Pfizer
SERB Pharmaceuticals’ Partnership with SFJ Pharmaceuticals
Freshfields advised SERB Pharmaceuticals on its U.S. Partnership. SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab...